TNYA

0.9469

6.25% -0.0631

Handel nachbörslich: .70 -0.2469 -26.07%

Tenaya Therapeutics Inc (TNYA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.01

Offen:

$1.02

24-Stunden-Volumen:

1.31M

Relative Volume:

0.35

Marktkapitalisierung:

$78.59M

Einnahmen:

Nettoeinkommen (Verlust:

$-117.23M

KGV:

-0.6576

EPS:

-1.44

Netto-Cashflow:

$-95.25M

1W Leistung:

-12.32%

1M Leistung:

-9.82%

6M Leistung:

-62.57%

1J Leistung:

-85.80%

1-Tages-Spanne:

$0.94

$1.025

1-Wochen-Bereich:

$0.94

$1.09

52-Wochen-Spanne:

$0.8606

$7.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Firmenname

Tenaya Therapeutics Inc

Sektor

Healthcare (1189)

Branche

Biotechnology (682)

Telefon

415-865-2066

Adresse

171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO

Mitarbeiter

140

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TNYA's Discussions on Twitter

Vergleichen Sie TNYA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNYA Tenaya Therapeutics Inc	0.9469	78.59M	0	-117.23M	-95.25M	-1.44
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-10	Eingeleitet	William Blair	Outperform
2023-11-30	Eingeleitet	Leerink Partners	Outperform
2022-06-15	Eingeleitet	H.C. Wainwright	Buy

Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten

04:25 AM

Tenaya Therapeutics announces securities offering - Investing.com India

04:25 AM

04:11 AM

Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire

04:11 AM

04:10 AM

Heart Disease Biotech Tenaya Seeks Fresh Capital Through Complex Warrant Offering - StockTitan

04:10 AM

08:27 AM

Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - The Manila Times

08:27 AM

08:00 AM

Can Tenaya's Heart Disease Therapies Impress Investors at March Conferences? - StockTitan

08:00 AM

Feb 27, 2025

H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock - MSN

Feb 27, 2025

Feb 26, 2025

Monitoring Tenaya Therapeutics Inc (TNYA) after recent insider movements - Knox Daily

Feb 26, 2025

Feb 22, 2025

Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World

Feb 22, 2025

Feb 20, 2025

Taking on analysts’ expectations and winning: Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 20, 2025

Feb 14, 2025

SG Americas Securities LLC Purchases 15,777 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Feb 14, 2025

Feb 12, 2025

It is Poised to be a Bull Market for Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 12, 2025

Feb 11, 2025

Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News

Feb 11, 2025

Feb 10, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Feb 10, 2025

Tenaya Therapeutics appoints new interim principal accounting officer - MSN

Feb 10, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $17.33 - Defense World

Feb 10, 2025

Feb 07, 2025

Tenaya Therapeutics appoints new interim principal accounting officer By Investing.com - Investing.com Canada

Feb 07, 2025

Tenaya Therapeutics Appoints Interim Accounting Officer - TipRanks

Feb 07, 2025